Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Closing in on human immunodeficiency virus–1

Nature Medicine volume 2, pages 274–275 (1996)Cite this article

Antiretroviral therapy back on track with HIV-1 protease inhibitors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Aboulker, J.P. & Swart, A.M. Preliminary analysis of the Concorde trial. Lancet 329, 889–890 (1993).

    Article  Google Scholar 

  2. Fischl, M.A. et al. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. Ann. Intern. Med. 122, 24–32 (1995).

    Article  CAS  Google Scholar 

  3. Delfraissy, J.F. et al. Abstracts of the IXth Int. Conference on AIDS, Berlin, Germany, p.69 (1993).

  4. Danner, S.A. et al. Abstracts of the IXth Int. Conference on AIDS, Berlin, Germany, p.69 (1993).

  5. Chow, Y.K. et al. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy. Nature 361, 650–654 (1993).

    Article  CAS  Google Scholar 

  6. Emini, E.A. et al. HIV and multidrug resistance. Nature 364, 679 (1993).

    Article  CAS  Google Scholar 

  7. Larder, B.A., Kellam, P. & Kemp, S.D. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature 365, 451–453 (1993).

    Article  CAS  Google Scholar 

  8. Mellors, J.W. Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 175 (1996).

  9. Hammer, S.M., Katzenstein, D.A., Hughes, M.D., Hirsch, M.S. & Merigan, T.C. Abstracts 3rd Conf. Retroviruses and Opportunistic Infections, Washington, DC, 175 (1996).

  10. Cameron, B. et al. Abstracts 3rd Conf. Retrovir. & Opportun. Infect., Washington, DC, p.162 (1996).

  11. Freimuth, W.W. et al. Abstracts 3rd Conf. Retrovir. & Opportun. Infect., Washington, DC, p.162 (1996).

  12. Gulick, R. et al. Abstracts 3rd Conf. Retrovir. & Opportun. Infect., Washington, DC, p.162 (1996).

  13. Mathez, D. et al. Abstracts 3rd Conf. Retrovir. & Opportun. Infect., Washington, DC, p. 106 (1996).

    Google Scholar 

  14. Coffin, J.M. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483–489 (1995).

    Article  CAS  Google Scholar 

  15. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995).

    Article  CAS  Google Scholar 

  16. Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).

    Article  CAS  Google Scholar 

  17. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M. & Ho, D.D. Abstracts 3rd Conf. Retrovir. & Opportun. Infect., Washington, DC, p.174 (1996).

  18. Mellors, J. et al. Abstracts 35th Intersci. Conf. on Antimicrobial Agents and Chemotherapy, San Francisco, California, 235 (1995).

  19. Condra, J.H. et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569–571 (1995).

    Article  CAS  Google Scholar 

  20. Steigbigel, R.T. et al Abstracts 3rd Conf. Retrovir. & Opportun. Infect., Washington, DC, p.80 (1996).

  21. Danner, S.A. et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N. Engl. J. Med. 333, 1528–1533 (1995).

    Article  CAS  Google Scholar 

  22. Markowitz, M. et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N. Engl. J. Med. 333, 1534–1539 (1995).

    Article  CAS  Google Scholar 

  23. Schapiro, J.M., Winters, M.A., Kozal, M.J. & Merigan, T.C. Abstracts 35th Intersci. Conf. Antimicrobial Agents and Chemotherapy, San Francisco, California, p.S8 (1995).

Download references

Author information

Authors and Affiliations

  1. Department of Veterans Affairs Medical Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA

    John W. Mellors

Authors
  1. John W. Mellors
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mellors, J. Closing in on human immunodeficiency virus–1. Nat Med 2, 274–275 (1996). https://doi.org/10.1038/nm0396-274

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0396-274

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing